CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	May 04, 2014	Apr. 28, 2013
Cash flows from operating activities:
Net loss	$ (9,163)	$ (8,969)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	17,708	17,932
Deferred financing cost amortization	592	2,171
Share-based compensation expense	5,742	6,887
Gain on insurance recovery	(1,311)	0
Provision for doubtful accounts	585	1,100
Benefit from deferred income taxes	(5,884)	(4,772)
Excess tax benefits from share-based compensation arrangements	(760)	0
Changes in operating assets and liabilities:
Accounts receivable	25,132	19,812
Inventories	(14,140)	(19,764)
Income tax receivable	(2)	(381)
Prepaid expenses and other	862	286
Accounts payable	(43,610)	(15,425)
Accrued expenses	(6,473)	(2,389)
Other, net	214	(278)
Net cash used in operating activities	(30,508)	(3,790)
Cash flows from investing activities:
Capital expenditures	(10,004)	(12,715)
Proceeds from insurance	1,311	0
Net cash used in investing activities	(8,693)	(12,715)
Cash flows from financing activities:
Proceeds from stock options exercised	0	674
Increase in restricted cash	0	1,375
Payments on term loan	(1,196)	(10,375)
Payments on note payable	(547)	(593)
Proceeds from Amended ABL Facility	47,000	17,000
Payments on Amended ABL Facility	(47,745)	(17,633)
Payment of financing costs	(75)	(97)
Excess tax benefits from share-based compensation arrangements	760	948
Purchase of treasury stock	(23,743)	(2,369)
Net cash used in financing activities	(25,546)	(11,070)
Effect of exchange rate changes on cash and cash equivalents	(221)	(45)
Net decrease in cash and cash equivalents	(64,968)	(27,620)
Cash and cash equivalents at beginning of period	77,436	55,158
Cash and cash equivalents at end of period	$ 12,468	$ 27,538